Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Capricor Therapeutics Inc (NASDAQ: CAPR) closed at $2.39M up 14371557% from its previous closing price of $11.94. In other words, the price has increased by $14371557 from its previous closing price. On the day, 14.37 million shares were traded. CAPR stock price reached its highest trading level at $11.46 during the session, while it also had its lowest trading level at $6.07.
Ratios:
For a deeper understanding of Capricor Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.55 and its Current Ratio is at 6.55. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Roth Capital on May 20, 2025, initiated with a Buy rating and assigned the stock a target price of $31.
On October 21, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $35.
On May 17, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.Oppenheimer initiated its Outperform rating on May 17, 2024, with a $14 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 20 ’24 when Nippon Shinyaku Co Ltd bought 2,798,507 shares for $5.36 per share. The transaction valued at 14,999,998 led to the insider holds 7,090,351 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 377546432 and an Enterprise Value of 234018688. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.75 while its Price-to-Book (P/B) ratio in mrq is 2.96. Its current Enterprise Value per Revenue stands at 13.478 whereas that against EBITDA is -4.195.
Stock Price History:
The Beta on a monthly basis for CAPR is 0.85, which has changed by 0.7244259 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, CAPR has reached a high of $23.40, while it has fallen to a 52-week low of $3.52. The 50-Day Moving Average of the stock is -23.70%, while the 200-Day Moving Average is calculated to be -38.23%.
Shares Statistics:
For the past three months, CAPR has traded an average of 2.39M shares per day and 3398730 over the past ten days. A total of 45.68M shares are outstanding, with a floating share count of 40.15M. Insiders hold about 12.16% of the company’s shares, while institutions hold 40.49% stake in the company. Shares short for CAPR as of 1748563200 were 11081704 with a Short Ratio of 4.64, compared to 1745971200 on 10340629. Therefore, it implies a Short% of Shares Outstanding of 11081704 and a Short% of Float of 27.58.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
